✨ Your Portfolio is fetched and updated from zerodha.
Small Hospitals
Market Cap
₹6,334 Cr.
P/E
59.52

Key Ratios

Market cap
Market cap
6,334 Cr
PE
PE
59.52
Prom Holding
Prom Holding
71.06 %
ROE (%)
ROE (%)
16.60
ROCE (%)
ROCE (%)
26.79
Div Yield (%)
Div Yield (%)
1.76
Sales
Sales
723 Cr
OPM (%)
OPM (%)
28.40 %
Debt to Equity
Debt to Equity
-

About

Thyrocare Technologies Ltd. is India's first fully automated diagnostic laboratory with a focu… Read more
Low
658
52W Range
High
1435
  • Thyrocare Tech.
  • Vimta Labs
  • Krsnaa Diagnostics
  • TJI Diagnostic Chains

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operating Profit Break-Up

Capex

Pathology vs Radiology

Asset Break-Up

Operational Metrics

    Select a Metric
    • Number of Daily Patients - Diagnostic Centres (Ths)
    • Number of Samples - Quarterly (Million)
    • No of Tests - Quarterly (Mn)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Thyrocare Technologies Ltd. Business

    Thyrocare Technologies Ltd. is India's first fully automated diagnostic laboratory, offering quality services at affordable rates to laboratories and hospitals in India and abroad through its Centralized and Regional Processing Laboratories.

    Thyrocare Tech. major competitors are Vimta Labs, Krsnaa Diagnostics, Metropolis Health., Vijaya Diagnostic, Nidan Labs. & Health, Dr. Lal Pathlabs, Cupid.
    Market Cap of Thyrocare Tech. is ₹6,396 Crs.
    While the median market cap of its peers are ₹5,598 Crs.

    Thyrocare Tech. seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material